Arcus Biosciences, Inc. (RCUS:NYSE) closed at $22.12 on October 16, 2026, down 3.07% on the day. The stock trades 30.3% below its 52-week high of $31.74 and 37.9% above its 52-week low of $16.04. Over the past year, it gained 34.3%. Arcus Biosciences, Inc. is part of the Health Care sector (Major Pharmaceuticals).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -9.12% | -13.39% | -21.48% | -2.73% | +34.30% |
In 252 trading sessions since October 16, 2025, RCUS closed higher on 136 days (54%). Its best day was March 2, 2026 (+17.53%) and its worst was December 12, 2025 (-14.36%). The stock moved 10% or more in a single session 4 times.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on developing and commercializing cancer immunotherapies.
Find more stocks like RCUS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.